AZTR
Price:
$0.3663
Market Cap:
$3.74M
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Industry
Biotechnology
IPO Date
2023-06-20
Stock Exchange
AMEX
Ticker
AZTR
According to Azitra, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.25. This represents a change of 41.38% compared to the average of -0.18 of the last 4 quarters.
The mean historical PE Ratio of Azitra, Inc. over the last ten years is -3.25. The current -0.25 PE Ratio has changed 668.68% with respect to the historical average. Over the past ten years (40 quarters), AZTR's PE Ratio was at its highest in in the September 2025 quarter at -0.00. The PE Ratio was at its lowest in in the June 2022 quarter at -7.90.
Average
-3.25
Median
-3.08
Minimum
-6.68
Maximum
-0.18
Discovering the peaks and valleys of Azitra, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.18
Minimum Annual Increase = -89.95%
Minimum Annual PE Ratio = -6.68
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.18 | -68.11% |
| 2023 | -0.56 | -89.95% |
| 2022 | -5.59 | -16.30% |
The current PE Ratio of Azitra, Inc. (AZTR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.11
5-year avg
-3.25
10-year avg
-3.25
Azitra, Inc.’s PE Ratio is less than Onconetix, Inc. (-0.08), greater than Jasper Therapeutics, Inc. (-0.43), greater than SciSparc Ltd. (-0.56), less than Silexion Therapeutics Ltd. (-0.10), less than Indaptus Therapeutics, Inc. (-0.07), less than Scinai Immunotherapeutics Ltd. (0.37), less than Salarius Pharmaceuticals, Inc. (-0.09), less than Revelation Biosciences, Inc. (-0.25), less than Lipella Pharmaceuticals Inc. (-0.00), less than Enveric Biosciences, Inc. (-0.13),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.08 | $1.68M | |
| -0.43 | $29.99M | |
| -0.56 | $910.97K | |
| -0.10 | $1.73M | |
| -0.07 | $3.74M | |
| 0.37 | $1.41M | |
| -0.09 | $5.28M | |
| -0.25 | $6.10M | |
| -0.00 | $1.43M | |
| -0.13 | $3.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Azitra, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Azitra, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Azitra, Inc.'s PE Ratio?
How is the PE Ratio calculated for Azitra, Inc. (AZTR)?
What is the highest PE Ratio for Azitra, Inc. (AZTR)?
What is the 3-year average PE Ratio for Azitra, Inc. (AZTR)?
What is the 5-year average PE Ratio for Azitra, Inc. (AZTR)?
How does the current PE Ratio for Azitra, Inc. (AZTR) compare to its historical average?